CISPLATIN NEPHROTOXICITY
Clinical trials for CISPLATIN NEPHROTOXICITY explained in plain language.
Never miss a new study
Get alerted when new CISPLATIN NEPHROTOXICITY trials appear
Sign up with your email to follow new studies for CISPLATIN NEPHROTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common diabetes drug may shield kidneys from chemo damage
Disease control Recruiting nowThis study tests whether dapagliflozin, a drug used for diabetes, can prevent kidney damage caused by platinum-based chemotherapy in people with solid tumors. About 46 participants will receive either dapagliflozin or a placebo for a few days around their chemo session. Researche…
Matched conditions: CISPLATIN NEPHROTOXICITY
Phase: PHASE2 • Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Antioxidant pill may shield kidneys from chemo damage
Symptom relief Recruiting nowThis study tests whether taking alpha-lipoic acid, a natural antioxidant, can prevent kidney damage in cancer patients receiving cisplatin chemotherapy. About 50 adults with solid tumors will receive either alpha-lipoic acid or a placebo alongside their chemo. Researchers will mo…
Matched conditions: CISPLATIN NEPHROTOXICITY
Phase: PHASE2 • Sponsor: Minia University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC